These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
476 related articles for article (PubMed ID: 29445134)
1. The long non-coding RNA FOXD2-AS1 promotes bladder cancer progression and recurrence through a positive feedback loop with Akt and E2F1. Su F; He W; Chen C; Liu M; Liu H; Xue F; Bi J; Xu D; Zhao Y; Huang J; Lin T; Jiang C Cell Death Dis; 2018 Feb; 9(2):233. PubMed ID: 29445134 [TBL] [Abstract][Full Text] [Related]
2. LncRNA FOXD2-AS1 promotes the growth, invasion and migration of OSCC cells by regulating the MiR-185-5p/PLOD1/Akt/mTOR pathway. Liu J; Zhang Y; Wu J; Liu X; Li L; Zhang J Cancer Genet; 2024 Jun; 284-285():48-57. PubMed ID: 38729078 [TBL] [Abstract][Full Text] [Related]
3. The lncRNA ELF3-AS1 promotes bladder cancer progression by interaction with Krüppel-like factor 8. Guo Y; Chen D; Su X; Chen J; Li Y Biochem Biophys Res Commun; 2019 Jan; 508(3):762-768. PubMed ID: 30528231 [TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA NNT-AS1 sponges miR-424/E2F1 to promote the tumorigenesis and cell cycle progression of gastric cancer. Chen B; Zhao Q; Guan L; Lv H; Bie L; Huang J; Chen XB J Cell Mol Med; 2018 Oct; 22(10):4751-4759. PubMed ID: 30006956 [TBL] [Abstract][Full Text] [Related]
5. Long noncoding FOXD2-AS1 is activated by CREB1 and promotes cell proliferation and metastasis in glioma by sponging miR-185 through targeting AKT1. Dong H; Cao W; Xue J Biochem Biophys Res Commun; 2019 Jan; 508(4):1074-1081. PubMed ID: 30553445 [TBL] [Abstract][Full Text] [Related]
6. LncRNA TP73-AS1 promoted the progression of lung adenocarcinoma via PI3K/AKT pathway. Liu C; Ren L; Deng J; Wang S Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30541897 [TBL] [Abstract][Full Text] [Related]
7. Nuclear lncRNA HOXD-AS1 suppresses colorectal carcinoma growth and metastasis via inhibiting HOXD3-induced integrin β3 transcriptional activating and MAPK/AKT signalling. Yang MH; Zhao L; Wang L; Ou-Yang W; Hu SS; Li WL; Ai ML; Wang YQ; Han Y; Li TT; Ding YQ; Wang S Mol Cancer; 2019 Mar; 18(1):31. PubMed ID: 30823921 [TBL] [Abstract][Full Text] [Related]
8. LncRNA-SLC16A1-AS1 induces metabolic reprogramming during Bladder Cancer progression as target and co-activator of E2F1. Logotheti S; Marquardt S; Gupta SK; Richter C; Edelhäuser BAH; Engelmann D; Brenmoehl J; Söhnchen C; Murr N; Alpers M; Singh KP; Wolkenhauer O; Heckl D; Spitschak A; Pützer BM Theranostics; 2020; 10(21):9620-9643. PubMed ID: 32863950 [TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA FOXD2-AS1 accelerates the gemcitabine-resistance of bladder cancer by sponging miR-143. An Q; Zhou L; Xu N Biomed Pharmacother; 2018 Jul; 103():415-420. PubMed ID: 29674277 [TBL] [Abstract][Full Text] [Related]
10. FoxD2-AS1 promotes glioma progression by regulating miR-185-5P/HMGA2 axis and PI3K/AKT signaling pathway. Ni W; Xia Y; Bi Y; Wen F; Hu D; Luo L Aging (Albany NY); 2019 Mar; 11(5):1427-1439. PubMed ID: 30860979 [TBL] [Abstract][Full Text] [Related]
11. High expression of SMYD3 indicates poor survival outcome and promotes tumour progression through an IGF-1R/AKT/E2F-1 positive feedback loop in bladder cancer. Wang G; Huang Y; Yang F; Tian X; Wang K; Liu L; Fan Y; Li X; Li L; Shi B; Hao Y; Xia C; Nie Q; Xin Y; Shi Z; Ma L; Xu D; Liu C Aging (Albany NY); 2020 Feb; 12(3):2030-2048. PubMed ID: 32007952 [TBL] [Abstract][Full Text] [Related]
12. lncRNA ADAMTS9-AS1 promotes bladder cancer cell invasion, migration, and inhibits apoptosis and autophagy through PI3K/AKT/mTOR signaling pathway. Yang G; Li Z; Dong L; Zhou F Int J Biochem Cell Biol; 2021 Nov; 140():106069. PubMed ID: 34428588 [TBL] [Abstract][Full Text] [Related]
13. Long Noncoding RNA (lncRNA) FOXD2-AS1 Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma by Regulating MiR-185/AKT Axis. Chen Z; Zhang Z; Zhao D; Feng W; Meng F; Han S; Lin B; Shi X Med Sci Monit; 2019 Dec; 25():9618-9629. PubMed ID: 31841454 [TBL] [Abstract][Full Text] [Related]
14. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells. Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672 [TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway. Qiao X; Lv SX; Qiao Y; Li QP; Ye B; Wang CC; Miao L Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8630-8639. PubMed ID: 30575903 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of the Long Noncoding RNA FOXD2-AS1 Promotes Cisplatin Resistance in Esophageal Squamous Cell Carcinoma Through the miR-195/Akt/mTOR Axis. Liu H; Zhang J; Luo X; Zeng M; Xu L; Zhang Q; Liu H; Guo J; Xu L Oncol Res; 2020 Feb; 28(1):65-73. PubMed ID: 31558183 [TBL] [Abstract][Full Text] [Related]
17. lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer. Qiu F; Zhang MR; Zhou Z; Pu JX; Zhao XJ J Cell Biochem; 2019 Jun; 120(6):10821-10829. PubMed ID: 30672010 [TBL] [Abstract][Full Text] [Related]
18. Upregulation of long non-coding RNA ROR1-AS1 promotes cell growth and migration in bladder cancer by regulation of miR-504. Chen Q; Fu L PLoS One; 2020; 15(1):e0227568. PubMed ID: 31929567 [TBL] [Abstract][Full Text] [Related]
19. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis. Liu ZB; Wang JA; Lv RQ Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1418-1427. PubMed ID: 30840262 [TBL] [Abstract][Full Text] [Related]
20. HIF-1α induced long noncoding RNA FOXD2-AS1 promotes the osteosarcoma through repressing p21. Ren Z; Hu Y; Li G; Kang Y; Liu Y; Zhao H Biomed Pharmacother; 2019 Sep; 117():109104. PubMed ID: 31228799 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]